Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. | Pharmaceutics | 2022 | 35890396 | PubTator, text mining | PubMed |
| Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta. | Pharmaceutics | 2022 | 35890272 | PubTator, text mining | PubMed |
| Modelling the Human Blood-Brain Barrier in Huntington Disease. | Int J Mol Sci | 2022 | 35887162 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of the Hub Genes Involved in Irinotecan Resistance in Colorectal Cancer. | Biomedicines | 2022 | 35885025 | PubTator, text mining | PubMed |
| Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature. | Cancers (Basel) | 2022 | 35884482 | PubTator, text mining | PubMed |
| Antioxidant and Neuroprotective Effects of Paeonol against Oxidative Stress and Altered Carrier-Mediated Transport System on NSC-34 Cell Lines. | Antioxidants (Basel) | 2022 | 35883881 | PubTator, text mining | PubMed |
| In Vitro Toxicity Evaluation of Cyanotoxins Cylindrospermopsin and Microcystin-LR on Human Kidney HEK293 Cells. | Toxins (Basel) | 2022 | 35878167 | PubTator, text mining | PubMed |
| Microcystin-LR incorporated into colonic cells through probenecid-sensitive transporters leads to upregulated MCP-1 expression induced by JNK activation. | Toxicol Rep | 2022 | 35875256 | PubTator, text mining | PubMed |
| Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians. | Open Forum Infect Dis | 2022 | 35866101 | PubTator, text mining | PubMed |
| Association of Physical Activity With Bioactive Lipids and Cardiovascular Events. | Circ Res | 2022 | 35862024 | PubTator, text mining | PubMed |
| Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia-A narrative review. | United European Gastroenterol J | 2022 | 35860851 | PubTator, text mining | PubMed |
| Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. | Mol Cancer | 2022 | 35843942 | PubTator, text mining | PubMed |
| Genetics of progressive supranuclear palsy in a Chinese population. | Neurobiol Dis | 2022 | 35842134 | PubTator, text mining | PubMed |
| Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension. | Chest | 2022 | 35841932 | PubTator, text mining | PubMed |
| Comparison of the inhibitory properties of the fruit component naringenin and its glycosides against OATP1A2 genetic variants. | Drug Metab Pharmacokinet | 2022 | 35841754 | PubTator, text mining | PubMed |
| Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. | Drug Deliv | 2022 | 35815678 | PubTator, text mining | PubMed |
| Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms. | Front Cell Dev Biol | 2022 | 35813212 | PubTator, text mining | PubMed |
| Inhibitory effects of Triphala on CYP isoforms in vitro and its pharmacokinetic interactions with phenacetin and midazolam in rats. | Heliyon | 2022 | 35785236 | PubTator, text mining | PubMed |
| Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier. | J Pharmacol Exp Ther | 2022 | 35779861 | PubTator, text mining | PubMed |
| Pathophysiology of sepsis-induced cholestasis: A review. | JGH Open | 2022 | 35774351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=26